Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus

PurposeThe optimal target for glycated hemoglobin (HbA1c) has not been well defined in peritoneal dialysis (PD) patients with diabetes mellitus.MethodsThe objective of our study was to examine the predictive value of predialysis and time-averaged follow-up HbA1c values on technique and patient survival in diabetic PD patients treated in the Toronto General Hospital Home Peritoneal Dialysis Unit, between January 1, 2003 and December 31, 2008 with a median follow-up period of 30 ± 23 months.ResultsNinety-one patients (mean age 64 ± 13 years-old) were included in this retrospective study. Patients were followed between 3 and 91 months (mean duration 30 ± 23 months). During this period, 40 patients died. We found no statistically significant correlation between baseline predialysis HbA1c values and technique and patient survival. Time-averaged follow-up HbA1c in increments <6.5 %, 6.5–8 %, and >8 % showed no significant survival difference among groups.ConclusionsThere was no significant correlation of baseline and time-averaged follow-up HbA1c values with patient and PD technique survival.